A new publication from ISAB and partners has radical implications for the future of toxicology testing, airborne pollution research and IVIVC (In Vitro In Vivo Collaboration) the early…
ISAB technology was profiled in two King’s College London posters and cited by a Pat Burnell New Innovation Award nominee at DDL27. “It reflects our growing influence as…
ISAB technology was profiled in two King’s College London posters and cited by a Pat Burnell New Innovation Award nominee at DDL27. “It reflects our growing influence as…
Dow Chemical Group and King’s College London (KCL) purchased PreciseInhale, and the number of client posters and publications validating the system grew rapidly. ISAB CEO Fredrik Sjövall explains…
PhD researcher Savvina Chortorea tried out PreciseInhale and ran some opening tests using challenging nanomaterials at ISAB’s recent in-lab seminar day. What were the results, and what did…
On October 12 Hana Barosova from the University of Fribourg attended ISAB’s in-lab aerosol seminar in Stockholm. Her team is researching how inhaling certain nanomaterials could cause severe…
A new vaccination based on antigen-nanocarriers was discussed recently at the ISAB labs. Kiel University researcher Judith Heidland visited to explore how PreciseInhale could further support her research,…
Bioaerosols: What will be the biological effects? On September 4-9 ISAB took PreciseInhale to Tours in central France for the European Aerosol Assembly’s (EAA’s) 2016 Conference. Interest was…
Bioaerosols: What will be the biological effects? On September 4-9 ISAB took PreciseInhale to Tours in central France for the European Aerosol Assembly’s (EAA’s) 2016 Conference. Interest was…
On October 13, invited scientists travel to Stockholm for Experiences of Aerosol Exposure, a one-day seminar with ISAB founder Per Gerde, plus guest speakers from in vitro to…
